276 related articles for article (PubMed ID: 20029048)
1. Combined effect of total nucleated cell dose and HLA match on transplantation outcome in 1061 cord blood recipients with hematologic malignancies.
Barker JN; Scaradavou A; Stevens CE
Blood; 2010 Mar; 115(9):1843-9. PubMed ID: 20029048
[TBL] [Abstract][Full Text] [Related]
2. [The impact of HLA matching on outcome of single unit unrelated cord blood transplantation: a retrospective single center clinical analysis].
Sun G; Sun Z; Liu H; Zheng C; Tang B; Zhu X; Song K
Zhonghua Xue Ye Xue Za Zhi; 2014 Aug; 35(8):678-83. PubMed ID: 25152111
[TBL] [Abstract][Full Text] [Related]
3. Reexposure of cord blood to noninherited maternal HLA antigens improves transplant outcome in hematological malignancies.
van Rood JJ; Stevens CE; Smits J; Carrier C; Carpenter C; Scaradavou A
Proc Natl Acad Sci U S A; 2009 Nov; 106(47):19952-7. PubMed ID: 19901324
[TBL] [Abstract][Full Text] [Related]
4. The impact of anti-HLA antibodies on unrelated cord blood transplantations.
Takanashi M; Atsuta Y; Fujiwara K; Kodo H; Kai S; Sato H; Kohsaki M; Azuma H; Tanaka H; Ogawa A; Nakajima K; Kato S
Blood; 2010 Oct; 116(15):2839-46. PubMed ID: 20628152
[TBL] [Abstract][Full Text] [Related]
5. Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies.
Kurtzberg J; Prasad VK; Carter SL; Wagner JE; Baxter-Lowe LA; Wall D; Kapoor N; Guinan EC; Feig SA; Wagner EL; Kernan NA;
Blood; 2008 Nov; 112(10):4318-27. PubMed ID: 18723429
[TBL] [Abstract][Full Text] [Related]
6. Sustained donor engraftment in recipients of double-unit cord blood transplantation is possible despite donor-specific human leukoctye antigen antibodies.
Dahi PB; Barone J; Devlin SM; Byam C; Lubin M; Ponce DM; Giralt S; Kernan NA; Scaradavou A; Hsu SH; Barker JN
Biol Blood Marrow Transplant; 2014 May; 20(5):735-9. PubMed ID: 24462980
[TBL] [Abstract][Full Text] [Related]
7. HLA mismatch direction in cord blood transplantation: impact on outcome and implications for cord blood unit selection.
Stevens CE; Carrier C; Carpenter C; Sung D; Scaradavou A
Blood; 2011 Oct; 118(14):3969-78. PubMed ID: 21750317
[TBL] [Abstract][Full Text] [Related]
8. Graft-versus-host disease after double-unit cord blood transplantation has unique features and an association with engrafting unit-to-recipient HLA match.
Ponce DM; Gonzales A; Lubin M; Castro-Malaspina H; Giralt S; Goldberg JD; Hanash AM; Jakubowski A; Jenq R; Papadopoulos EB; Perales MA; van den Brink MR; Young JW; Boulad F; O'Reilly RJ; Prockop S; Small TN; Scaradavou A; Kernan NA; Stevens CE; Barker JN
Biol Blood Marrow Transplant; 2013 Jun; 19(6):904-11. PubMed ID: 23416854
[TBL] [Abstract][Full Text] [Related]
9. Better allele-level matching improves transplant-related mortality after double cord blood transplantation.
Oran B; Cao K; Saliba RM; Rezvani K; de Lima M; Ahmed S; Hosing CM; Popat UR; Carmazzi Y; Kebriaei P; Nieto Y; Rondon G; Willis D; Shah N; Parmar S; Olson A; Moore B; Marin D; Mehta R; Fernández-Viña M; Champlin RE; Shpall EJ
Haematologica; 2015 Oct; 100(10):1361-70. PubMed ID: 26250579
[TBL] [Abstract][Full Text] [Related]
10. Influence of infused cell dose and HLA match on engraftment after double-unit cord blood allografts.
Avery S; Shi W; Lubin M; Gonzales AM; Heller G; Castro-Malaspina H; Giralt S; Kernan NA; Scaradavou A; Barker JN
Blood; 2011 Mar; 117(12):3277-85; quiz 3478. PubMed ID: 21149633
[TBL] [Abstract][Full Text] [Related]
11. Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival.
van Besien K; Hari P; Zhang MJ; Liu HT; Stock W; Godley L; Odenike O; Larson R; Bishop M; Wickrema A; Gergis U; Mayer S; Shore T; Tsai S; Rhodes J; Cushing MM; Korman S; Artz A
Haematologica; 2016 May; 101(5):634-43. PubMed ID: 26869630
[TBL] [Abstract][Full Text] [Related]
12. Association between Nondominant Unit Total Nucleated Cell Dose and Engraftment in Myeloablative Double-Unit Cord Blood Transplantation.
Purtill D; Stevens CE; Lubin M; Ponce D; Hanash A; Giralt S; Scaradavou A; Young JW; Barker JN
Biol Blood Marrow Transplant; 2015 Nov; 21(11):1981-4. PubMed ID: 26211983
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice.
Gluckman E; Rocha V; Arcese W; Michel G; Sanz G; Chan KW; Takahashi TA; Ortega J; Filipovich A; Locatelli F; Asano S; Fagioli F; Vowels M; Sirvent A; Laporte JP; Tiedemann K; Amadori S; Abecassis M; Bordigoni P; Diez B; Shaw PJ; Vora A; Caniglia M; Garnier F; Ionescu I; Garcia J; Koegler G; Rebulla P; Chevret S;
Exp Hematol; 2004 Apr; 32(4):397-407. PubMed ID: 15050751
[TBL] [Abstract][Full Text] [Related]
14. Different effects of HLA disparity on transplant outcomes after single-unit cord blood transplantation between pediatric and adult patients with leukemia.
Atsuta Y; Kanda J; Takanashi M; Morishima Y; Taniguchi S; Takahashi S; Ogawa H; Ohashi K; Ohno Y; Onishi Y; Aotsuka N; Nagamura-Inoue T; Kato K; Kanda Y;
Haematologica; 2013 May; 98(5):814-22. PubMed ID: 23349300
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up and factors influencing outcomes after related HLA-identical cord blood transplantation for patients with malignancies: an analysis on behalf of Eurocord-EBMT.
Herr AL; Kabbara N; Bonfim CM; Teira P; Locatelli F; Tiedemann K; Lankester A; Jouet JP; Messina C; Bertrand Y; Díaz de Heredia C; Peters C; Chaves W; Nabhan SK; Ionescu I; Gluckman E; Rocha V
Blood; 2010 Sep; 116(11):1849-56. PubMed ID: 20538797
[TBL] [Abstract][Full Text] [Related]
16. Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility study.
Cohen S; Roy J; Lachance S; Delisle JS; Marinier A; Busque L; Roy DC; Barabé F; Ahmad I; Bambace N; Bernard L; Kiss T; Bouchard P; Caudrelier P; Landais S; Larochelle F; Chagraoui J; Lehnertz B; Corneau S; Tomellini E; van Kampen JJA; Cornelissen JJ; Dumont-Lagacé M; Tanguay M; Li Q; Lemieux S; Zandstra PW; Sauvageau G
Lancet Haematol; 2020 Feb; 7(2):e134-e145. PubMed ID: 31704264
[TBL] [Abstract][Full Text] [Related]
17. Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity.
Migliaccio AR; Adamson JW; Stevens CE; Dobrila NL; Carrier CM; Rubinstein P
Blood; 2000 Oct; 96(8):2717-22. PubMed ID: 11023503
[TBL] [Abstract][Full Text] [Related]
18. Negative effect of KIR alloreactivity in recipients of umbilical cord blood transplant depends on transplantation conditioning intensity.
Brunstein CG; Wagner JE; Weisdorf DJ; Cooley S; Noreen H; Barker JN; DeFor T; Verneris MR; Blazar BR; Miller JS
Blood; 2009 May; 113(22):5628-34. PubMed ID: 19329778
[TBL] [Abstract][Full Text] [Related]
19. High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation.
Ponce DM; Hilden P; Mumaw C; Devlin SM; Lubin M; Giralt S; Goldberg JD; Hanash A; Hsu K; Jenq R; Perales MA; Sauter C; van den Brink MR; Young JW; Brentjens R; Kernan NA; Prockop SE; O'Reilly RJ; Scaradavou A; Paczesny S; Barker JN
Blood; 2015 Jan; 125(1):199-205. PubMed ID: 25377785
[TBL] [Abstract][Full Text] [Related]
20. Availability of cord blood extends allogeneic hematopoietic stem cell transplant access to racial and ethnic minorities.
Barker JN; Byam CE; Kernan NA; Lee SS; Hawke RM; Doshi KA; Wells DS; Heller G; Papadopoulos EB; Scaradavou A; Young JW; van den Brink MR
Biol Blood Marrow Transplant; 2010 Nov; 16(11):1541-8. PubMed ID: 20800103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
